Shares rise on Almirall's rising revenue and income

Almirall’s (ALM: MC) first quarterly results of 2019 suggest a continuation of the previous year’s theme, by pointing to rising revenue and growth.

The Spanish dermatology specialist saw its revenue in total increase by 15% to 232.2 million euros ($261.3 million) in the period from January to March, compared to the same three months in 2018.

Normalized net income hit 32.6 million euros, up 5.6% on a year ago, and earnings before interest, taxes, depreciation and amortization (EBITDA) hit 80.2 million euros, a 38% jump.